2Volker Heinemann. Present and future treatment of pancreatic cancer (J). Seminars in Oncology, 2002,29 (3) : 23.
3Cullinan SA,Moertel CG,Flemin TR,et al.A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma.JAMA,1985,253:2061-2067.
4Burris HA,Moore MJ.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:A randomized trial.J Clin Oncol,1997,15:2403-2413.
5孙燕 周际昌.临床肿瘤内科手册[M].北京：人民卫生出版社,2003.586-591.
6Volker H.Present and Future Treatment of Pancreatic Cancer[J].Seminars in Oncology,2002,29(3):23.
7Reni M, Passoni P, Panucci MG, et al.Definitive results of a phase Ⅱ trial of cisplatin, epirubicin, continuous infusion fluorouracil, and gemcitabine in stage Ⅳ pancreatic adenocarcinoma[J]. J Clin 0ncol,2001,19(10):2679-2686.
8Rougier P, Adenis A, Ducreux M, et al.A phase II study : docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma[J]. Eur J cancer, 2000, 36(8):1016- 1025.
9Choi CW, Choi IK, Seo JH, et al. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas[J]. Am J Clin Oncol, 2000, 23 (4):425- 428.
10Kuwsaki I, Hatakeyama K. Adjuvant systemic chemotherapy with gemcitabine for stage 1V pancreatic cancer: a preliminary report of initial experience[J]. Chemotherapy, 2005, 51(6):305-310.
